PHREESIA INC
PHRNYSE🏆 #2559 by market capEarnings Dec 7US Equity
$12.35▼ $0.02 (−0.16%)
Latest quoteTrack PHR
Get earnings, price moves & breaking news on Telegram
24h▼ 0.2%
7d▼ 2.9%
14d▲ 11.9%
30d▲ 23.3%
ytd▼ 27.0%
1y▼ 46.8%
🏦Market Cap
$767M
Small Cap
📈Revenue Growth (YoY)
12.9%
Healthy
📊Gross Margin
67.5%
High
💵FCF Margin
13.3%
Healthy
⚖️P/S Ratio
1.5x
Cheap
Otter Score
84
Strong
PHREESIA INC
PHRAnalyst Ratings
Price
$12.35
Total
26
Raised
0
Lowered
3
Avg PT
$12.14
H / L
$16 / $10
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Barclays | Reiterated | Equal Weight | 2026-10-12 | $11.00 | −10.90% |
Raymond James | Downgraded | Outperform → Market Perform | 2026-09-08 | $33.00 | +167.20% |
DA Davidson | Reiterated | Buy | 2026-09-04 | $13.00 | +5.30% |
Baird | Reiterated | Neutral | 2026-09-04 | — | — |
Freedom Capital Markets | Reiterated | Buy | 2026-09-03 | — | — |
Needham | Reiterated | Buy | 2026-09-03 | $29.00 | +134.80% |
Canaccord Genuity | Reiterated | Buy | 2026-09-03 | $16.00 | +29.60% |
Wells Fargo | Reiterated | Equal Weight | 2026-09-03 | $10.00 | −19.00% |
RBC Capital | Reiterated | Outperform | 2026-09-03 | $23.00 | +86.20% |
Truist Securities | Reiterated | Hold | 2026-05-29 | — | — |
Citigroup | Reiterated | Neutral | 2026-05-28 | — | — |
Keybanc | Reiterated | Overweight | 2026-04-13 | $32.00 | +159.10% |
Citizens | Downgraded | Market Outperform → Market Perform | 2026-04-01 | — | — |
Stephens & Co. | Reiterated | Overweight | 2026-03-31 | — | — |
JP Morgan | Downgraded | Overweight → Neutral | 2026-03-31 | — | — |
BMO Capital | Reiterated | Outperform | 2026-03-31 | — | — |
Mizuho | Reiterated | Outperform | 2026-03-24 | — | — |
JMP Securities | Reiterated | Market Outperform | 2025-09-08 | $34.00 | +175.30% |
Piper Sandler | Reiterated | Overweight | 2025-09-05 | $12.00 | −2.80% |
Guggenheim | Reiterated | Buy | 2023-03-29 | — | — |
SVB Leerink | Reiterated | Outperform | 2023-01-05 | — | — |
Berenberg | Reiterated | Buy | 2021-06-08 | — | — |
KeyBanc | Reiterated | Overweight | 2021-03-31 | $32.00 | +159.10% |
Cantor Fitzgerald | Reiterated | Overweight | 2020-01-09 | $70.00 | +466.80% |
Piper Jaffray | Reiterated | Overweight | 2019-08-12 | — | — |
Chardan Capital | Reiterated | Buy | 2019-07-23 | — | — |
Institution
Barclays
Reiterated · Equal Weight · 2026-10-12
$11.00
−10.90%
Raymond James
Downgraded · Outperform → Market Perform · 2026-09-08
$33.00
+167.20%
DA Davidson
Reiterated · Buy · 2026-09-04
$13.00
+5.30%
Baird
Reiterated · Neutral · 2026-09-04
—
—
Freedom Capital Markets
Reiterated · Buy · 2026-09-03
—
—
Needham
Reiterated · Buy · 2026-09-03
$29.00
+134.80%
Canaccord Genuity
Reiterated · Buy · 2026-09-03
$16.00
+29.60%
Wells Fargo
Reiterated · Equal Weight · 2026-09-03
$10.00
−19.00%
RBC Capital
Reiterated · Outperform · 2026-09-03
$23.00
+86.20%
Truist Securities
Reiterated · Hold · 2026-05-29
—
—
Citigroup
Reiterated · Neutral · 2026-05-28
—
—
Keybanc
Reiterated · Overweight · 2026-04-13
$32.00
+159.10%
Citizens
Downgraded · Market Outperform → Market Perform · 2026-04-01
—
—
Stephens & Co.
Reiterated · Overweight · 2026-03-31
—
—
JP Morgan
Downgraded · Overweight → Neutral · 2026-03-31
—
—
BMO Capital
Reiterated · Outperform · 2026-03-31
—
—
Mizuho
Reiterated · Outperform · 2026-03-24
—
—
JMP Securities
Reiterated · Market Outperform · 2025-09-08
$34.00
+175.30%
Piper Sandler
Reiterated · Overweight · 2025-09-05
$12.00
−2.80%
Guggenheim
Reiterated · Buy · 2023-03-29
—
—
SVB Leerink
Reiterated · Outperform · 2023-01-05
—
—
Berenberg
Reiterated · Buy · 2021-06-08
—
—
KeyBanc
Reiterated · Overweight · 2021-03-31
$32.00
+159.10%
Cantor Fitzgerald
Reiterated · Overweight · 2020-01-09
$70.00
+466.80%
Piper Jaffray
Reiterated · Overweight · 2019-08-12
—
—
Chardan Capital
Reiterated · Buy · 2019-07-23
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space